These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interaction with normal cells suppresses the transformed phenotype of v-myc-transformed quail muscle cells. La Rocca SA; Grossi M; Falcone G; Alemà S; Tatò F Cell; 1989 Jul; 58(1):123-31. PubMed ID: 2752417 [TBL] [Abstract][Full Text] [Related]
5. Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Schneider MD; Perryman MB; Payne PA; Spizz G; Roberts R; Olson EN Mol Cell Biol; 1987 May; 7(5):1973-7. PubMed ID: 3299056 [TBL] [Abstract][Full Text] [Related]
6. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
7. Expression of v-src alters the expression of myogenic regulatory factor genes. Yoon H; Boettiger D Oncogene; 1994 Mar; 9(3):801-7. PubMed ID: 8108122 [TBL] [Abstract][Full Text] [Related]
8. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels. Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454 [TBL] [Abstract][Full Text] [Related]
9. Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells. MacAuley A; Pawson T J Virol; 1988 Dec; 62(12):4712-21. PubMed ID: 2846881 [TBL] [Abstract][Full Text] [Related]
10. Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes. Shalloway D; Johnson PJ; Freed EO; Coulter D; Flood WA Mol Cell Biol; 1987 Oct; 7(10):3582-90. PubMed ID: 2446117 [TBL] [Abstract][Full Text] [Related]
11. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Lassar AB; Thayer MJ; Overell RW; Weintraub H Cell; 1989 Aug; 58(4):659-67. PubMed ID: 2548731 [TBL] [Abstract][Full Text] [Related]
12. Expression of the c-ski proto-oncogene during cell cycle arrest and myogenic differentiation. Ambrose MR; Bottazzi ME; Goodenow MM DNA Cell Biol; 1995 Aug; 14(8):701-7. PubMed ID: 7646817 [TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of src family protooncogenes in T cell activation and its modulation by cyclosporine. Furue M; Katz SI; Kawakami Y; Kawakami T J Immunol; 1990 Jan; 144(2):736-9. PubMed ID: 2104905 [TBL] [Abstract][Full Text] [Related]
14. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. La Rocca SA; Crouch DH; Gillespie DA Oncogene; 1994 Dec; 9(12):3499-508. PubMed ID: 7970710 [TBL] [Abstract][Full Text] [Related]
15. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines. Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of N-myc, c-myc and c-src proto-oncogenes during the course of induced differentiation of murine embryonal carcinoma cells. Sumegi J; Sejersen T; Björklund H; Klein G; Ringertz NR Curr Top Microbiol Immunol; 1986; 132():297-304. PubMed ID: 2431836 [No Abstract] [Full Text] [Related]
17. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Edmondson DG; Olson EN Genes Dev; 1989 May; 3(5):628-40. PubMed ID: 2473006 [TBL] [Abstract][Full Text] [Related]
18. Genetics of src: structure and functional organization of a protein tyrosine kinase. Parsons JT; Weber MJ Curr Top Microbiol Immunol; 1989; 147():79-127. PubMed ID: 2482802 [No Abstract] [Full Text] [Related]